Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease

Abstract
Biomarkers to assist in the diagnosis and medical management of Alzheimer disease (AD) are a pressing need. We have employed a proteomic approach, microcapillary liquid chromatography mass spectrometry of proteins labeled with isotope-coded affinity

This publication has 0 references indexed in Scilit: